CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.
Founded
2008
Raised
$33.5M
Follow us
Alexa global traffic share
06 Jan 2015
$20,000,000
Venture capital (Series C)
31 Jul 2012
$11,000,000
Venture capital (Series B)
03 Mar 2010
$2,500,000
Convertible Note